Although there remain limited studies and a lack of rigorous trials, available evidence suggests that methotrexate may be an effective and safe treatment for chronic chikungunya arthritis, according ...

Methotrexate is a strong medicine. The FDA approved it to treat adults with severe, disabling psoriasis that cannot be controlled with medicine applied to the skin or light treatments. Methotrexate ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adding methotrexate to adalimumab therapy significantly ...

Adalimumab monotherapy and combination with methotrexate showed similar drug survival and PASI75 response rates in plaque psoriasis patients. Methotrexate reduced antidrug antibody levels but did not ...

For decades, methotrexate has formed the foundation of therapy in RA, either alone or in combination with other drugs; however, its mechanisms of action remain poorly understood, and many patients ...

Atopic dermatitis on the neck. Methotrexate treatment is associated with a significant improvement in symptoms of moderate to severe atopic dermatitis compared with cyclosporine treatment. Treatment ...

The American College of Rheumatology (ACR) has issued new guidelines on the treatment of rheumatoid arthritis, addressing questions about initial treatment with methotrexate and minimizing reliance on ...

In July 2022, the US Food and Drug Administration (FDA) expanded the labeling of Krystexxa (pegloticase; Horizon Therapeutics), a PEGylated uric acid-specific enzyme, to include coadministration with ...

Pregnant female patients with rheumatoid arthritis (RA) treated with methotrexate and leflunomide within 3 months of conception faced an increased possibility of adverse pregnancy outcomes, ...

This prospective randomized study assessed success and subsequent pregnancy rates after the medical vs surgical treatment of extrauterine pregnancies. Patients with intact extrauterine pregnancies < 3 ...

Efficacy of Mindfulness-Based Cognitive Therapy on Late Post-Treatment Pain in Women Treated for Primary Breast Cancer: A Randomized Controlled Trial After a median of 6.9 years of follow-up, DFS was ...